Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Mouton

Showing results (181-190 of 392) with videos related to

Pageof 40
Sort By:
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|July 29, 2014
The role of azoles in the management of azole-resistant aspergillosis: from the bench to the bedsideSeyedmojtaba Seyedmousavi, Johan W Mouton, Willem J G Melchers, et al.
Antimicrobial Agents and Chemotherapy|August 25, 2010
Impact of cyp51A mutations on the pharmacokinetic and pharmacodynamic properties of voriconazole in a murine model of disseminated aspergillosisEleftheria Mavridou, Roger J M Bruggemann, Willem J G Melchers, et al.
Antimicrobial Agents and Chemotherapy|November 18, 2009
Efficacy of posaconazole against three clinical Aspergillus fumigatus isolates with mutations in the cyp51A geneEleftheria Mavridou, Roger J M Brüggemann, Willem J G Melchers, et al.
Journal of Clinical Microbiology|August 1, 2002
Comparison of the Etest and the sensititre colorimetric methods with the NCCLS proposed standard for antifungal susceptibility testing of Aspergillus speciesJoseph Meletiadis, Johan W Mouton, Jacques F G M Meis, et al.
Intensive Care Medicine|April 16, 1998
Lung overinflation without positive end-expiratory pressure promotes bacteremia after experimental Klebsiella pneumoniae inoculationS J Verbrugge, V Sorm, A van 't Veen, et al.
The Journal of Antimicrobial Chemotherapy|September 22, 2016
Impact of bacterial load on pharmacodynamics and susceptibility breakpoints for tigecycline and Klebsiella pneumoniaeMarilena Tsala, Sophia Vourli, George L Daikos, et al.
Diagnostic Microbiology and Infectious Disease|April 27, 2016
Bacteroides fragilis in biopsies of patients with major abscesses and diabetic foot infections: direct molecular versus culture-based detectionMark H T Stappers, Ferry Hagen, Peter Reimnitz, et al.
Antimicrobial Agents and Chemotherapy|January 1, 1997
Synergism between tobramycin and ceftazidime against a resistant Pseudomonas aeruginosa strain, tested in an in vitro pharmacokinetic modelJ G den Hollander, A M Horrevorts, M L van Goor, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1997
Comparative in vitro activities of trovafloxacin (CP-99,219) against 445 gram-positive isolates from patients with endocarditis and those with other bloodstream infectionsH P Endtz, J W Mouton, J G den Hollander, et al.
BMC Veterinary Research|September 7, 2016
Modelling concentrations of antimicrobial drugs: comparative pharmacokinetics of cephalosporin antimicrobials and accuracy of allometric scaling in food-producing and companion animalsFemke J Taverne, Ingeborg M van Geijlswijk, Dick J J Heederik, et al.
Pageof 40

Showing results (181-190 of 392) with videos related to

Sort By:
Pageof 40
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|July 29, 2014
The role of azoles in the management of azole-resistant aspergillosis: from the bench to the bedsideSeyedmojtaba Seyedmousavi, Johan W Mouton, Willem J G Melchers, et al.
Antimicrobial Agents and Chemotherapy|August 25, 2010
Impact of cyp51A mutations on the pharmacokinetic and pharmacodynamic properties of voriconazole in a murine model of disseminated aspergillosisEleftheria Mavridou, Roger J M Bruggemann, Willem J G Melchers, et al.
Antimicrobial Agents and Chemotherapy|November 18, 2009
Efficacy of posaconazole against three clinical Aspergillus fumigatus isolates with mutations in the cyp51A geneEleftheria Mavridou, Roger J M Brüggemann, Willem J G Melchers, et al.
Journal of Clinical Microbiology|August 1, 2002
Comparison of the Etest and the sensititre colorimetric methods with the NCCLS proposed standard for antifungal susceptibility testing of Aspergillus speciesJoseph Meletiadis, Johan W Mouton, Jacques F G M Meis, et al.
Intensive Care Medicine|April 16, 1998
Lung overinflation without positive end-expiratory pressure promotes bacteremia after experimental Klebsiella pneumoniae inoculationS J Verbrugge, V Sorm, A van 't Veen, et al.
The Journal of Antimicrobial Chemotherapy|September 22, 2016
Impact of bacterial load on pharmacodynamics and susceptibility breakpoints for tigecycline and Klebsiella pneumoniaeMarilena Tsala, Sophia Vourli, George L Daikos, et al.
Diagnostic Microbiology and Infectious Disease|April 27, 2016
Bacteroides fragilis in biopsies of patients with major abscesses and diabetic foot infections: direct molecular versus culture-based detectionMark H T Stappers, Ferry Hagen, Peter Reimnitz, et al.
Antimicrobial Agents and Chemotherapy|January 1, 1997
Synergism between tobramycin and ceftazidime against a resistant Pseudomonas aeruginosa strain, tested in an in vitro pharmacokinetic modelJ G den Hollander, A M Horrevorts, M L van Goor, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1997
Comparative in vitro activities of trovafloxacin (CP-99,219) against 445 gram-positive isolates from patients with endocarditis and those with other bloodstream infectionsH P Endtz, J W Mouton, J G den Hollander, et al.
BMC Veterinary Research|September 7, 2016
Modelling concentrations of antimicrobial drugs: comparative pharmacokinetics of cephalosporin antimicrobials and accuracy of allometric scaling in food-producing and companion animalsFemke J Taverne, Ingeborg M van Geijlswijk, Dick J J Heederik, et al.
Pageof 40